Cue Biopharma (CUE) Stock Chart & Stock Price History $0.73 +0.03 (+4.68%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cue Biopharma Stock Price Performance The Cue Biopharma (CUE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 24.97%, with a year-to-date return of -32.75%. In the past month, the stock has increased 14.35%, reflecting recent market activity. As of the latest close, Cue Biopharma traded at $0.70 with a market cap of $52.76 million and volume of 72,337 shares. Five years ago, the stock traded at $22.70, representing a 96.77% decrease over that period. At the time, it had a market cap of $641.26 million and a volume of 171,400 shares. Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.54%1 Month Performance+14.35%3 Month Performance+18.65%Year-To-Date Performance-32.75%1 Year Performance-24.97%5 Year Performance-96.77% CUE Stock Chart for Tuesday, July, 8, 2025 CUE Chart by TradingView Cue Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$0.69$0.70+1.77%$0.71$0.6772,337 shs$52.76 million07/04/2025$0.69$0.69$0.71$0.6766,632 shs$51.84 million07/03/2025$0.69$0.69-0.58%$0.71$0.6766,632 shs$51.84 million07/02/2025$0.67$0.69+2.91%$0.71$0.65224,880 shs$52.14 million07/01/2025$0.68$0.67-1.45%$0.70$0.65807,319 shs$50.67 million06/30/2025$0.74$0.68-7.92%$0.76$0.68149,456 shs$51.41 million06/27/2025$0.79$0.74-6.13%$0.79$0.74233,740 shs$55.83 million06/26/2025$0.79$0.79+0.43%$0.79$0.73103,140 shs$59.48 million06/25/2025$0.72$0.79+8.67%$0.88$0.72777,443 shs$59.23 million06/24/2025$0.65$0.72+11.28%$0.73$0.65998,426 shs$54.50 million Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$0.70$0.65-7.24%$0.70$0.65131,591 shs$48.98 million06/20/2025$0.66$0.70+6.90%$0.74$0.621.08 million shs$52.80 million06/19/2025$0.66$0.66$0.67$0.54458,578 shs$49.39 million06/18/2025$0.58$0.66+13.00%$0.67$0.54458,578 shs$49.39 million06/17/2025$0.59$0.58-1.68%$0.62$0.56128,032 shs$43.71 million06/16/2025$0.60$0.59-1.99%$0.63$0.57123,682 shs$44.46 million06/13/2025$0.64$0.60-5.30%$0.66$0.5996,984 shs$45.36 million06/12/2025$0.64$0.64-0.52%$0.66$0.62175,993 shs$47.90 million06/11/2025$0.63$0.64+0.85%$0.66$0.62118,449 shs$48.15 million06/10/2025$0.64$0.63-0.53%$0.67$0.62122,256 shs$47.74 million06/09/2025$0.64$0.64-0.62%$0.66$0.61121,790 shs$48.00 million Related Companies ProQR Therapeutics Stock Price Chart Nanobiotix Stock Price Chart Y-mAbs Therapeutics Stock Price Chart I-Mab Stock Price Chart Cardiff Oncology Stock Price Chart Inhibrx Biosciences Stock Price Chart MediWound Stock Price Chart SOPHiA GENETICS Stock Price Chart Monopar Therapeutics Stock Price Chart scPharmaceuticals Stock Price Chart Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CUE) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CUE Stock Alerts